Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria C Cid

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 6, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell ArteritisKaitlin A Quinn, Sovira Tan, Pauline Verdijk, et al.
Circulation|May 14, 2003
Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanismJosé Hernández-Rodríguez, Marta Segarra, Carme Vilardell, et al.
Frontiers in Immunology|May 8, 2018
Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory PathwaysGeorgina Espígol-Frigolé, Ester Planas-Rigol, Ester Lozano, et al.
Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2023
The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseasesBalazs Odler, Johanna Tieu, Katharina Artinger, et al.
Medicine|February 6, 2015
Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal studySergio Prieto-González, Ana García-Martínez, Itziar Tavera-Bahillo, et al.
Annals of the Rheumatic Diseases|September 21, 2012
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritisGeorgina Espígol-Frigolé, Marc Corbera-Bellalta, Ester Planas-Rigol, et al.
Autoimmunity Reviews|May 23, 2024
Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeuticsShuang Xu, William F Jiemy, Elisabeth Brouwer, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritisEster Planas-Rigol, Nekane Terrades-Garcia, Marc Corbera-Bellalta, et al.
Nature Reviews. Disease Primers|January 7, 2022
Large-vessel vasculitisDan Pugh, Maira Karabayas, Neil Basu, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Arthritis & Rheumatology (Hoboken, N.J.)|April 6, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell ArteritisKaitlin A Quinn, Sovira Tan, Pauline Verdijk, et al.
Circulation|May 14, 2003
Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanismJosé Hernández-Rodríguez, Marta Segarra, Carme Vilardell, et al.
Frontiers in Immunology|May 8, 2018
Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory PathwaysGeorgina Espígol-Frigolé, Ester Planas-Rigol, Ester Lozano, et al.
Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2023
The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseasesBalazs Odler, Johanna Tieu, Katharina Artinger, et al.
Medicine|February 6, 2015
Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal studySergio Prieto-González, Ana García-Martínez, Itziar Tavera-Bahillo, et al.
Annals of the Rheumatic Diseases|September 21, 2012
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritisGeorgina Espígol-Frigolé, Marc Corbera-Bellalta, Ester Planas-Rigol, et al.
Autoimmunity Reviews|May 23, 2024
Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeuticsShuang Xu, William F Jiemy, Elisabeth Brouwer, et al.
Annals of the Rheumatic Diseases|June 14, 2017
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritisEster Planas-Rigol, Nekane Terrades-Garcia, Marc Corbera-Bellalta, et al.
Nature Reviews. Disease Primers|January 7, 2022
Large-vessel vasculitisDan Pugh, Maira Karabayas, Neil Basu, et al.
Pageof 15